Novartis Launches 3-Day Feline NSAID



Published:

Novartis Animal Health launched Onsior (robenacoxib) tablets, a three-day non-steroidal anti-inflammatory drug for postoperative cats, the Greensboro, N.C., company reported today.

The drug is indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration. It is the first multidose oral NSAID to be approved for cats, Novartis reported.

The drug’s short blood half-life causes the active ingredient to be quickly eliminated from the blood while persisting longer at the site of inflamed tissue, allowing for once-a-day administration for up to three days, the company reported.

Side effects observed during a clinical field trial and six-month safety study included surgical site bleeding, infected surgery sites, lethargy, vomiting and inappetence.

The drug is indicated for cats weighing 5.5 pounds or heavier and at least 6 months old for a maximum of three days. The drug should not be used in cats that have a hypersensitivity to robenacoxib or known intolerance to NSAIDs and should not be administered in conjunction with any other oral or injectable NSAID or corticosteroid, according to Novartis.

 <HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Tuskegee Joins VMCAS Clearinghouse

Tuskegee and Tufts are the newest members of the centralized Veterinary Medical College Application Service.

More Pot for Pet Owners Means Pets Get Access Too

Veterinarians brace for rise in pet toxicity cases as more states move to legalize or decriminalize marijuana use

Vets Hope to Cash in at Global Pet Expo

Two companies operated by holistic veterinarians will push food and calming pet products during one of the industry’s largest events.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module